<DOC>
	<DOCNO>NCT02186678</DOCNO>
	<brief_summary>18F-FDOPA PET-CT currently gold standard evaluation Pheochromocytomas Paragangliomas ( PHEO - PGL ) since tumor also decarboxylate amino acid dihydroxyphenylalanine ( DOPA ) . This property common tumor APUD system ( Amine Precursor Uptake Decarboxylation ) . In recent year , PET ( Positron Emission Tomography ) image use peptide receptor gain increase role management NETs . The use somatostatin agonist , radiolabeled gallium-68 ( 68Ga ) enables target Somatostatin receptor ( SSTRs ) PET resolution . This improved diagnosis SSTRs-expressing tumor , include PGLs . In present study , investigator choose DOTATATE ( Nal3-octreotate ) rather agonist ( DOTATOC DOTANOC ) , high affinity SST2 overexpressed subtype PHEO/PGL . However , performance 18F-FDOPA PET-CT 68Ga-DOTATATE PET-CT never compare clinical setting .</brief_summary>
	<brief_title>Comparison Diagnostic Performances 68Ga-DOTATATE PET-CT 18F-FDOPA PET-CT Paragangliomas Pheochromocytomas Evaluation</brief_title>
	<detailed_description />
	<mesh_term>Pheochromocytoma</mesh_term>
	<mesh_term>Paraganglioma</mesh_term>
	<mesh_term>Carotid Body Tumor</mesh_term>
	<criteria>Age â‰¥ 18 PHEO PGL : initial stag restaging Reference image within last 2 month : multiphasic cervicothoracoabdominal CT scan , 18FFDOPA PETCT head neck MRI ( head neck localization Pregnant breastfeeding woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>